ClinicalTrials.Veeva

Menu

Visual Rehabilitation and Depression in Visually Impaired Patients with AMD (RET 06-24)

F

Fondazione G.B. Bietti, IRCCS

Status

Enrolling

Conditions

AMD - Age-Related Macular Degeneration
Depression Disorders
Anxiety

Treatments

Other: visual rehabilitation program

Study type

Observational

Funder types

Other

Identifiers

NCT06906003
RET 06-24

Details and patient eligibility

About

Purpose: The aim of this study is to evaluate the impact of visual rehabilitation in visually impaired patients with advanced AMD by the use of questionnaires on the anxiety and depression status.

Study design: prospective observational study. The study is carried out at the IRCCS Fondazione G.B.Bietti and at the UO Visual Rehabilitation, S. Alessio - Margherita di Savoia.

Study procedures: Visit 1 (screening visit, at IRCCS Fondazione Bietti) After signing the informed consent, all patients received a complete ophthalmological examination, non-invasive diagnostic tests as optical coherence tomography, autofluorescence and microperimetry, and have to complete the questionnaires on the state of anxiety and depression (GAD-7 and PHQ-9).

Visit 2 (at the Sant'Alessio Institute) for a 60-day visual rehabilitation program scheduled in 5 group meetings.

Visit 3 (end-of-study visit, at IRCCS Fondazione G.B. Bietti) complete ophthalmological examination, as per clinical practice, non-invasive diagnostic tests such as microperimetry, optical coherence tomography and autofluorescence and administration of the Patient Health Questionnaire-9 (PHQ-9) questionnaires for depression and the General Anxiety Disorder (GAD-7) questionnaires for anxiety.

Enrollment

22 estimated patients

Sex

All

Ages

55+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subjects ≥ 55 years
  2. Moderate and severe visual impairment (BCVA ≥1/10 and ≤2/10)
  3. Diagnosis of advanced non-exudative age-related macular degeneration (AMD)
  4. Informed consent freely granted and acquired before the start of the study
  5. Ability to understand and willingness to follow the study instructions and procedures

Exclusion criteria

  1. Visual impairment due to other ocular diseases
  2. Mild visual impairment or partial or total blindness
  3. Exudative age-related macular degeneration undergoing intravitreal drug treatment

Trial contacts and locations

1

Loading...

Central trial contact

Eliana Costanzo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems